Cargando…

Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases

INTRODUCTION: Coronavirus Disease 19 (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Since the outbreak, neuropsychiatric presentations such as delirium have been developing. OBJECTIVES: Our aim is to describe sociodemographic and clinical differences between...

Descripción completa

Detalles Bibliográficos
Autores principales: García Hernández, D., Calls Samora, M., Llimona González, A., Dinamarca, F., Casanovas, F., Pérez Oms, A., Llimona Sánchez, C., Oller Canet, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564836/
http://dx.doi.org/10.1192/j.eurpsy.2022.1227
_version_ 1784808744550400000
author García Hernández, D.
Calls Samora, M.
Llimona González, A.
Dinamarca, F.
Casanovas, F.
Pérez Oms, A.
Llimona Sánchez, C.
Oller Canet, S.
author_facet García Hernández, D.
Calls Samora, M.
Llimona González, A.
Dinamarca, F.
Casanovas, F.
Pérez Oms, A.
Llimona Sánchez, C.
Oller Canet, S.
author_sort García Hernández, D.
collection PubMed
description INTRODUCTION: Coronavirus Disease 19 (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Since the outbreak, neuropsychiatric presentations such as delirium have been developing. OBJECTIVES: Our aim is to describe sociodemographic and clinical differences between inpatients cursing with Acute Confusional Syndrome (ACS) with and without COVID-19 pneumonia. METHODS: This is an observational-descriptive study. All patients attended by the liaison psychiatry service of Hospital del Mar, between February and April 2020, with ACS diagnosis were included. The sample was divided in 2 groups (with and without COVID-19 pneumonia). Sociodemographic and clinical variables including sex, age, previous somatic or psychiatric history, ACS risk factors, ACS subtype and pharmacological treatment were compared. Chi-square and U Mann Whitney tests were used. RESULTS: The total sample was 62 patients. 43.5% were women with a mean age of 71,7 (SD 11,3). Covid pneumonia group included 26 patients. There was a higher percentage of Hypoxemia in Covid pneumonia patients (p<0,001). There were significant differences between Covid pneumonia group and ACS in relation to: a previous diagnosis of Ischemic Heart Disease (p=0,007), Heart Failure (p=0,029) and Nephropathy (p=0,022). Dexmedetomidine (p=0,001) was highly used for ACS treatment in Covid pneumonia patients. CONCLUSIONS: In this sample, patients with ACS and Covid pneumonia had a bigger rate of hypoxemia and previous history of Ischemic Heart Disease, Heart Failure and Nephropathy compared to the rest of ACS patients. Dexmedetomidine was more commonly used for the treatment of ACS in Covid pneumonia group. More studies would be necessary to assess the significance. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9564836
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95648362022-10-17 Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases García Hernández, D. Calls Samora, M. Llimona González, A. Dinamarca, F. Casanovas, F. Pérez Oms, A. Llimona Sánchez, C. Oller Canet, S. Eur Psychiatry Abstract INTRODUCTION: Coronavirus Disease 19 (COVID-19) was declared a pandemic by the World Health Organization (WHO) in March 2020. Since the outbreak, neuropsychiatric presentations such as delirium have been developing. OBJECTIVES: Our aim is to describe sociodemographic and clinical differences between inpatients cursing with Acute Confusional Syndrome (ACS) with and without COVID-19 pneumonia. METHODS: This is an observational-descriptive study. All patients attended by the liaison psychiatry service of Hospital del Mar, between February and April 2020, with ACS diagnosis were included. The sample was divided in 2 groups (with and without COVID-19 pneumonia). Sociodemographic and clinical variables including sex, age, previous somatic or psychiatric history, ACS risk factors, ACS subtype and pharmacological treatment were compared. Chi-square and U Mann Whitney tests were used. RESULTS: The total sample was 62 patients. 43.5% were women with a mean age of 71,7 (SD 11,3). Covid pneumonia group included 26 patients. There was a higher percentage of Hypoxemia in Covid pneumonia patients (p<0,001). There were significant differences between Covid pneumonia group and ACS in relation to: a previous diagnosis of Ischemic Heart Disease (p=0,007), Heart Failure (p=0,029) and Nephropathy (p=0,022). Dexmedetomidine (p=0,001) was highly used for ACS treatment in Covid pneumonia patients. CONCLUSIONS: In this sample, patients with ACS and Covid pneumonia had a bigger rate of hypoxemia and previous history of Ischemic Heart Disease, Heart Failure and Nephropathy compared to the rest of ACS patients. Dexmedetomidine was more commonly used for the treatment of ACS in Covid pneumonia group. More studies would be necessary to assess the significance. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9564836/ http://dx.doi.org/10.1192/j.eurpsy.2022.1227 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
García Hernández, D.
Calls Samora, M.
Llimona González, A.
Dinamarca, F.
Casanovas, F.
Pérez Oms, A.
Llimona Sánchez, C.
Oller Canet, S.
Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title_full Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title_fullStr Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title_full_unstemmed Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title_short Acute Confusional Syndrome and Covid-19 disease. Clinical and Sociodemographic differences with other comorbid diseases
title_sort acute confusional syndrome and covid-19 disease. clinical and sociodemographic differences with other comorbid diseases
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564836/
http://dx.doi.org/10.1192/j.eurpsy.2022.1227
work_keys_str_mv AT garciahernandezd acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT callssamoram acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT llimonagonzaleza acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT dinamarcaf acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT casanovasf acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT perezomsa acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT llimonasanchezc acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases
AT ollercanets acuteconfusionalsyndromeandcovid19diseaseclinicalandsociodemographicdifferenceswithothercomorbiddiseases